Skip to main content
WeightCited

Magnesium für Metabolic Syndrome

B Evidenz Mindestens eine randomisierte Studie unterstützt dies, mit überwiegend konsistenten Ergebnissen.

Meta-analysis of 32 RCTs (n=2,382) found significant reductions in BMI, waist circumference, fasting glucose, and CRP. Each 100 mg/day increase in magnesium intake was associated with 5% lower metabolic syndrome risk. Up to 68% of Americans fail to meet the RDA.

B

Fazit

Meta-analysis of 32 RCTs (n=2,382) found significant reductions in BMI, waist circumference, fasting glucose, and CRP. Each 100 mg/day increase in magnesium intake was associated with 5% lower metabolic syndrome risk. Up to 68% of Americans fail to meet the RDA.

Key Study Findings

Case Reports 13.0 weeks
A case report of Gitelman syndrome in children.
Dose: 3 g Outcome: pain reduction

Population: Hypokalemia

Review
Consequences of Disturbing Manganese Homeostasis.
Dose: Manganese (Mn) - exposure assessment Outcome: Mn toxicity mechanisms on CNS

Population: General (manganese exposure review)

Randomized Controlled Trial n=48 26.0 weeks
Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for …
Dose: 100 mg/d vs.: control group Outcome: blood pressure

Population: hypertensive patients

Key Statistics

32

Studien

2382

Teilnehmer

↑

Positive

B

Bewertung

Referenced Papers

A Comprehensive Review of Nutritional Influences on the Serotonergic System. Review
Advances in nutrition … 2025 5 Zitierungen
Intake of fiber and micronutrients in patients with IBS. Other
Scandinavian journal of … 2025
Consequences of Disturbing Manganese Homeostasis. Review
International journal of … 2023 120 Zitierungen
A case report of Gitelman syndrome in children. Case Report
Medicine 2023
Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview. Review
International journal of … 2022 102 Zitierungen
[Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot]. Other
Nutricion hospitalaria 2021 20 Zitierungen
Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based studies. Other
Sleep 2019 38 Zitierungen
Evaluation of Dietary Intakes and Supplement Use in Paralympic Athletes. Other
Nutrients 2017 46 Zitierungen
[Restless legs syndrome and periodic limb movements during sleep in a patient with obstructive sleep apnea]. Other
Neurologia i neurochirurgia … 2004 2 Zitierungen
Magnesium, zinc, and chromium nutriture and physical activity. Review
The American journal … 2000 207 Zitierungen
Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … RCT
European journal of … 1986 22 Zitierungen
Depression or asthenia related to metabolic disturbances in obese patients after intestinal bypass surgery. Other
Acta psychiatrica Scandinavica 1979 22 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
310-420 mg/day (RDA)
sleepsupport:
200-400 mg glycinate before bed
weightmanagement:
250-500 mg elemental magnesium/day

Obergrenze: 350 mg/day from supplements only (laxative effect); no UL from food sources

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
3 g 13.0 weeks Mixed --
Manganese (Mn) - exposure assessment -- Negative --
100 mg/d 26.0 weeks Mixed 48

Beste Einnahmezeit: Evening (glycinate/threonate for sleep); with meals (citrate) to reduce GI effects

Safety & Side Effects

Gemeldete Nebenwirkungen

  • ⚠ Diarrhea (especially oxide form)
  • ⚠ Nausea
  • ⚠ Abdominal cramping
  • ⚠ Low blood pressure (at very high doses)

Bekannte Wechselwirkungen

  • ● Antibiotics (reduced absorption — take 2 hours apart)
  • ● Bisphosphonates (reduced absorption)
  • ● Diuretics (may increase or decrease levels)
  • ● Proton pump inhibitors (may deplete magnesium)

Tolerierbare Höchstaufnahmemenge: 350 mg/day from supplements only (laxative effect); no UL from food sources

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Magnesium help with Metabolic Syndrome?
Based on 32 studies with 2,382 participants, there is moderate evidence from clinical studies that Magnesium may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).
How much Magnesium should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 310-420 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Magnesium?
Reported side effects may include Diarrhea (especially oxide form), Nausea, Abdominal cramping, Low blood pressure (at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Magnesium and Metabolic Syndrome?
We rate the evidence as Grade B (Good Evidence). This rating is based on 32 peer-reviewed studies with 2,382 total participants. The overall direction of effect is positive.

Andere Inhaltsstoffe für Metabolic Syndrome

Berberine A Omega-3 B Taurine B

Magnesium für andere Beschwerden

Insulin Resistance B

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Justin Tang et al..
      Adv Nutr.
      2025.
      A Comprehensive Review of Nutritional Influences on the Serotonergic System.
      doi:10.1016/j.advnut.2025.100524
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Bodil Roth et al..
      Scand J Gastroenterol.
      2025.
      Intake of fiber and micronutrients in patients with IBS.
      doi:10.1080/00365521.2025.2535721
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Jacek Baj et al..
      Int J Mol Sci.
      2023.
      Consequences of Disturbing Manganese Homeostasis.
      doi:10.3390/ijms241914959
      PubMed
    
    4. 
    
    
  4. 
      [4]
      Jing Ying et al..
      Medicine (Baltimore).
      2023.
      A case report of Gitelman syndrome in children.
      doi:10.1097/MD.0000000000033509
      PubMed
    
    5. 
    
    
  5. 
      [5]
      Aniceta A Mikulska et al..
      Int J Mol Sci.
      2022.
      Metabolic Characteristics of Hashimoto's Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management-An Overview.
      doi:10.3390/ijms23126580
      PubMed
    
    6. 
    
    
  6. 
      [6]
      Rosa María Martínez García et al..
      Nutr Hosp.
      2021.
      [Nutrition in the prevention and healing of chronic wounds. Importance in improving the diabetic foot].
      doi:10.20960/nh.03800
      PubMed
    
    7. 
    
    
  7. 
      [7]
      András Szentkirályi et al..
      Sleep.
      2019.
      Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based studies.
      doi:10.1093/sleep/zsy237
      PubMed
    
    8. 
    
    
  8. 
      [8]
      Robyn F Madden et al..
      Nutrients.
      2017.
      Evaluation of Dietary Intakes and Supplement Use in Paralympic Athletes.
      doi:10.3390/nu9111266
      PubMed
    
    9. 
    
    
  9. 
      [9]
      Luiza Jonczak et al..
      Neurol Neurochir Pol.
      2004.
      [Restless legs syndrome and periodic limb movements during sleep in a patient with obstructive sleep apnea].
      
      PubMed
    
    10. 
    
    
  10. 
      [10]
      H C Lukaski.
      Am J Clin Nutr.
      2000.
      Magnesium, zinc, and chromium nutriture and physical activity.
      doi:10.1093/ajcn/72.2.585S
      PubMed
    
    11. 
    
    
  11. 
      [11]
      T Dyckner et al..
      Eur J Clin Pharmacol.
      1986.
      Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial …
      doi:10.1007/BF00542411
      PubMed
    
    12. 
    
    
  12. 
      [12]
      P Bech et al..
      Acta Psychiatr Scand.
      1979.
      Depression or asthenia related to metabolic disturbances in obese patients after intestinal bypass surgery.
      doi:10.1111/j.1600-0447.1979.tb00245.x
      PubMed
    
    13. 
    
  















    

        FDA-Haftungsausschluss:
        Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.